About Us
Leadership Team
Partnering
Corporate Presentation
Pipeline
Varoglutamstat
Clinical Development
Expanded Access Policy
Our Science
Investors & News
Stock Information
News&Events
Corporate Presentation
Financial Information
Corporate Governance
Shareholders´ Meetings
Email Alerts
Contact Us
Careers
✕
World Alzheimer’s Month
Probiodrug Presents Pre-clinical and Clinical Findings of PQ912, a QC-Inhibitor for Alzheimer’s Disease
Probiodrug announces its intention to launch an Initial Public Offering and listing on Euronext Amsterdam
Related posts
5th Biannual NUBIN Symposium on Biomarkers in Neurodegenerative Diseases
Read more